Friday, June 21, 2019 2:37:52 PM
Based on doing my research, I have learned that doing a reverse split is not in the plans for ADHC. Here is what the company released to clear the air on that matter:
https://americandiversifiedholding.com/
ADHC - Merger Coming Soon
New website with new products and services and full e-commerce capability coming soon. We are currently in the merger process. The merger may be announced anytime before the scheduled time frame without advance notice. Adhc interim management is aware That the reverse split language is causing some concerns for our shareholders. ADHC has no plans of doing any reverse split in the foreseeable future. The language inserted in the 8K is designed to protect all stakeholders that have invested significant amount of capital and currently hold restricted shares. In the future be it 3 or 5 or 15 years if and when The company decides to conduct a reverse split these shares would be protected from anti dilution. Adhc will issue an updated 8k or filing shortly.
v/r
Sterling
Exit Strategy & Etiquette Thoughts for a Stock
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128822531
I never give investing advice; only my beliefs for risks in a stock.
Recent ADHC News
- American Diversified Holdings Operating Division GlucoGuard Retains Global Contract Research Organization (CRO) to Begin Patient Studies as Required by the FDA • Newsfile • 04/01/2026 12:30:00 PM
- American Diversified Holdings Corporation (ADHC) Announces Internal Technology Initiative Within Universal Wellness AI Division • Newsfile • 01/06/2026 02:00:00 PM
- GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program • Newsfile • 11/25/2025 02:00:00 PM
- GlucoGuard Receives $43 Million Enterprise Valuation From Prominent CFA Led Harbinger Research • Newsfile • 11/04/2025 02:00:00 PM
- American Diversified Holdings Corporation Receives $5,000,000 (Five Million) Financing Commitment from an Institutional Investment Fund • Newsfile • 10/16/2025 01:00:00 PM
- GlucoGuard Receives Scope of Work (SOW) Proposal from Arete Bioscience for FDA Recommended Sleep Study • Newsfile • 10/14/2025 10:00:00 AM
